ARVINAS, INC.

ARVN

ARVINAS, INC.

ARVN

Insider Sentiment (TTM):

Last Purchase:2026-03-06Last Sale:2026-06-24Shares Purchased (TTM):50,000Shares Sold (TTM):126,256

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:51,878,117Shares Outstanding:64,000,000Institutional Ownership Pct.:81.06%

Earnings Market Reaction:

Filing Date:2026-05-11Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

ARVINAS, INC. (ARVN) — SEC Financial Statements & Analysis

ARVINAS, INC. (ARVN) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	87	143	102	115	81	101	85	155	88	312	114	91
Marketable Securities Current	528	543	686	746	873	939	1,036	1,074	1,081	949	885	948
Restricted Cash Current	-	0	-	-	-	0	0	6	6	6	6	6
Accounts Receivable Net Current	2	1	20	1	0	6	7	2	0	0	16	0
Other Receivables Net Current	5	5	7	11	8	8	8	10	7	7	5	5
Prepaid Expense And Other Assets Current	9	9	12	17	17	14	13	13	8	7	8	8
Assets Current	631	701	826	890	980	1,067	1,150	1,257	1,190	1,280	1,033	1,057
Property Plant And Equipment Net	6	5	5	6	7	7	7	10	10	12	13	13
Operating Lease Right Of Use Asset	8	8	9	9	10	9	1	2	2	3	3	4
Assets	648	718	844	909	1,001	1,091	1,167	1,280	1,213	1,305	1,058	1,084
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	62	70	56	53	71	72	76	78	76	92	91	75
Contract With Customer Liability Current	52	71	88	103	141	156	199	268	163	163	224	230
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	0	0
Operating Lease Liability Current	2	2	2	2	2	2	1	1	2	2	2	2
Liabilities Current	116	143	145	158	214	230	276	347	241	257	317	307
Contract With Customer Liability Noncurrent	138	134	127	134	118	292	305	331	361	386	282	311
Long Term Debt Noncurrent	0	0	0	1	1	1	1	1	1	1	1	1
Operating Lease Liability Noncurrent	6	7	7	8	8	7	0	0	0	1	1	2
Liabilities	261	284	280	300	341	530	581	679	603	645	601	620
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	-	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Retained Earnings Accumulated Deficit	-1,670	-1,612	-1,545	-1,510	-1,449	-1,532	-1,487	-1,437	-1,402	-1,333	-1,178	-1,114
Additional Paid In Capital	2,149	2,137	2,128	2,118	2,107	2,092	2,068	2,041	2,016	1,996	1,644	1,590
Accumulated Other Comprehensive Income Loss Net Of…	-0	1	1	1	2	1	4	-4	-4	-3	-9	-12
Treasury Stock Value	-	-	-20	-	-	-	-	-	-	-	-	-
Treasury Stock Common Value	-92	-92	-	-	-	0	-	-	-	-	-	-
Stockholders Equity	387	434	564	609	660	562	586	600	610	660	457	464
Liabilities And Stockholders Equity	648	718	844	909	1,001	1,091	1,167	1,280	1,213	1,305	1,058	1,084
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	-	-
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	-	-
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	-	-
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Issued	75	74	73	73	73	69	69	69	68	68	55	53
Shares Outstanding	65	64	71	73	73	69	69	69	68	68	55	53
Treasury Stock Common Shares	10	10	3	-	-	0	-	-	-	-	-	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-23.19%	-13.15%	-	-	-	-	-	-	-	-	-	-
2025	-9.96%	2.90%	1.66%	20.22%	28.62%	43.23%	31.56%	27.06%	34.69%	-11.56%	-11.08%	-26.60%
2024	-3.47%	-22.46%	-13.63%	-3.36%	-5.39%	0.07%	-6.51%	-33.19%	-34.74%	3.39%	-62.90%	-56.33%
2023	-	-	-	14.61%	-19.18%	-41.60%	32.66%	131.37%	107.03%	-12.73%	-27.68%	-31.93%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	5.44	4.92	5.70	5.64	4.58	4.64	4.17	3.62	4.94	4.98	3.26	3.44
Quick Ratio	5.36	4.85	5.62	5.53	4.50	4.58	4.12	3.58	4.91	4.95	3.23	3.42
Working Capital	514.80M	558.20M	681.40M	731.70M	765.70M	837.50M	873.60M	909.50M	949.50M	1.02B	715.70M	749.80M
Leverage & Debt
Debt to Equity	0.67	0.65	0.50	0.49	0.52	0.94	0.99	1.13	0.99	0.98	1.31	1.34
Interest Coverage TTM	-	-	-	-	-	-	-	-	-	-	-	-88.82
Debt Ratio	0.40	0.40	0.33	0.33	0.34	0.49	0.50	0.53	0.50	0.49	0.57	0.57
Efficiency & Turnover
Asset Turnover TTM	0.11	0.29	0.31	0.34	0.39	0.22	0.14	0.08	0.06	0.06	0.13	0.13
Days Sales Outstanding TTM	4.49	4.66	16.13	1.13	0.34	7.90	26.06	3.72	-	-	19.11	1.73
Receivables Turnover TTM	81.27	78.39	22.63	324.17	1,067.25	46.21	14.01	98.21	-	-	19.10	210.80
Per Share Metrics
Diluted EPS TTM	-3.46	-1.14	-0.80	-0.99	-0.64	-2.77	-4.28	-4.50	-4.95	-6.62	-5.46	-5.57
Free Cash Flow Per Share TTM	-4.01	-3.89	-4.50	-5.47	-3.49	-3.63	-3.60	-3.02	-4.97	-6.32	-6.28	-6.04
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-283.78%	-45.13%	-32.66%	-31.79%	-22.37%	-94.99%	-221.85%	-397.64%	-556.94%	-511.46%	-195.36%	-191.02%
Net Profit Margin TTM	-247.54%	-30.77%	-18.73%	-19.47%	-10.92%	-75.51%	-191.56%	-346.62%	-497.62%	-467.90%	-185.20%	-188.24%
Growth Metrics
Net Revenue Growth (1Y)	-79.06%	-0.30%	93.85%	299.57%	498.74%	235.54%	1.00%	-40.99%	-48.11%	-40.26%	25.79%	53.64%
Net Income Growth (1Y)	374.89%	-59.38%	-81.04%	-77.55%	-86.87%	-45.85%	4.47%	8.67%	17.87%	30.02%	16.99%	27.67%
EPS Growth (1Y)	437.96%	-58.80%	-81.33%	-77.89%	-87.01%	-58.20%	-21.61%	-19.29%	-12.38%	24.63%	15.04%	27.19%
Valuation Metrics
P/E TTM	-3.07	-10.41	-10.66	-7.40	-10.92	-6.93	-5.75	-5.92	-8.34	-6.22	-3.60	-4.45
P/B	1.75	1.94	1.11	0.88	0.77	2.45	3.03	3.19	4.85	3.46	2.32	2.86
P/S TTM	7.59	3.20	2.00	1.44	1.19	5.23	11.02	20.51	41.51	29.10	6.66	8.38
Market Cap	678.40M	840.87M	623.66M	537.28M	508.95M	1.38B	1.78B	1.91B	2.96B	2.28B	1.06B	1.33B
Enterprise Value	591.40M	698.37M	522.56M	422.88M	428.45M	1.28B	1.69B	1.75B	2.87B	2.32B	944.32M	1.23B
Calculated Values
Free Cash Flow TTM	-256.90M	-275.70M	-329.50M	-399.00M	-252.80M	-261.10M	-259.90M	-217.10M	-356.00M	-350.70M	-339.80M	-322.70M
Net Debt	-87.00M	-142.50M	-101.10M	-114.40M	-80.50M	-99.90M	-84.60M	-159.60M	-92.80M	34.60M	-118.20M	-95.10M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-24Sale

Owner: Saik, Andrew

Title: Chief Financial Officer

Shares: 5,696

Price/Share: $8.16

Value: $46,479.36

Shares Owned: 187,432

Relationship: Officer

Ownership: Direct

2026-06-17Sale

Owner: Cacace, Angela M

Title: Chief Scientific Officer

Shares: 2,576

Price/Share: $7.60

Value: $19,577.60

Shares Owned: 180,390

Relationship: Officer

Ownership: Direct

2026-05-21Sale

Owner: Teel, Randy

Title: President and CEO

Shares: 2,209

Price/Share: $9.04

Value: $19,969.36

Shares Owned: 285,009

Relationship: Director,Officer

Ownership: Direct

2026-05-11Sale

Owner: Teel, Randy

Title: President and CEO

Shares: 9,657

Price/Share: $9.94

Value: $95,990.58

Shares Owned: 287,218

Relationship: Director,Officer

Ownership: Direct

2026-05-11Sale

Owner: Berkowitz, Noah

Title: Chief Medical Officer

Shares: 11,108

Price/Share: $9.94

Value: $110,413.52

Shares Owned: 191,395

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-24	Saik, Andrew	Officer	Chief Financial Officer	Direct	Sale	5,696	8.16	$46,479.36	187,432	4
2026-06-17	Cacace, Angela M	Officer	Chief Scientific Officer	Direct	Sale	2,576	7.60	$19,577.60	180,390	4
2026-05-21	Teel, Randy	Director,Officer	President and CEO	Direct	Sale	2,209	9.04	$19,969.36	285,009	4
2026-05-11	Teel, Randy	Director,Officer	President and CEO	Direct	Sale	9,657	9.94	$95,990.58	287,218	4
2026-05-11	Berkowitz, Noah	Officer	Chief Medical Officer	Direct	Sale	11,108	9.94	$110,413.52	191,395	4
2026-05-11	Cacace, Angela M	Officer	Chief Scientific Officer	Direct	Sale	9,657	9.94	$95,990.58	182,966	4
2026-05-11	Saik, Andrew	Officer	Chief Financial Officer	Direct	Sale	11,139	9.94	$110,721.66	193,128	4
2026-05-11	Loomis, David K	Officer	VP, Chief Accounting Officer	Direct	Sale	1,919	9.94	$19,074.86	40,193	4
2026-03-18	Berkowitz, Noah	Officer	Chief Medical Officer	Direct	Sale	6,435	11.10	$71,428.50	202,503	4
2026-03-06	Morrison, Briggs	Director	-	Direct	Purchase	20,000	13.40	$268,000.00	96,021	4
2026-02-27	Houston, John G	Director	-	Direct	Sale	35,297	13.21	$466,273.37	1,122,183	4
2026-02-23	Cacace, Angela M	Officer	Chief Scientific Officer	Direct	Sale	3,609	12.16	$43,885.44	147,623	4
2026-02-23	Teel, Randy	Director,Officer	President and CEO	Direct	Sale	4,786	12.16	$58,197.76	149,696	4
2026-02-23	Loomis, David K	Officer	Chief Accounting Officer	Direct	Sale	1,108	12.16	$13,473.28	29,692	4
2026-02-13	Cacace, Angela M	Officer	Chief Scientific Officer	Direct	Sale	4,592	11.89	$54,598.88	151,232	4
2026-02-13	Loomis, David K	Officer	Chief Accounting Officer	Direct	Sale	1,016	11.89	$12,080.24	30,800	4
2026-02-13	Berkowitz, Noah	Officer	Chief Medical Officer	Direct	Sale	5,685	11.89	$67,594.65	163,938	4
2026-02-13	Teel, Randy	Director,Officer	President and CEO	Direct	Sale	4,403	11.89	$52,351.67	154,482	4
2026-02-13	Saik, Andrew	Officer	Chief Financial Officer	Direct	Sale	5,134	11.89	$61,043.26	159,267	4
2025-11-07	Loomis, David K	Officer	Chief Accounting Officer	Direct	Sale	230	9.89	$2,274.70	31,697	4
2025-09-22	Morrison, Briggs	Director	-	Direct	Purchase	30,000	7.57	$227,100.00	76,021	4
2025-06-24	Saik, Andrew	Officer	Chief Financial Officer	Direct	Sale	5,700	7.61	$43,377.00	164,401	4
2025-06-17	Cacace, Angela M	Officer	Chief Scientific Officer	Direct	Sale	2,583	7.49	$19,346.67	154,248	4
2025-03-18	Berkowitz, Noah	Officer	Chief Medical Officer	Direct	Sale	8,658	8.59	$74,372.22	110,023	4
2025-02-24	Loomis, David K	Officer	Chief Accounting Officer	Direct	Sale	1,214	16.75	$20,334.50	18,863	4
2025-02-24	Cacace, Angela M	Officer	Chief Scientific Officer	Direct	Sale	4,207	16.65	$70,046.55	97,231	4
2025-02-24	Taylor, Ian	Officer	President, R&D	Direct	Sale	9,020	16.65	$150,183.00	159,121	4
2025-02-24	Houston, John G	Director,Officer	President and CEO	Direct	Sale	31,338	16.65	$521,777.70	1,157,480	4
2024-11-07	Loomis, David K	Officer	Chief Accounting Officer	Direct	Sale	231	27.69	$6,396.39	8,040	4
2024-02-23	Taylor, Ian	Officer	Chief Scientific Officer	Direct	Sale	1,701	47.05	$80,032.05	147,522	4
2024-02-23	Peck, Ronald	Officer	Chief Medical Officer	Direct	Sale	1,699	47.05	$79,937.95	67,516	4
2024-02-23	Cassidy, Sean A	Officer	Chief Financial Officer	Direct	Sale	1,702	47.05	$80,079.10	181,916	4
2024-02-23	Houston, John G	Director,Officer	President and CEO	Direct	Sale	5,196	47.05	$244,471.80	1,036,681	4
2023-08-11	Peck, Ronald	Officer	Chief Medical Officer	Direct	Sale	1,324	24.39	$32,292.36	29,965	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

81.06%

Inst. Shares: 51,878,117

Shares Outstanding: 64,000,000

2025-12-31

76.00%

Inst. Shares: 53,884,280

Shares Outstanding: 70,900,000

2025-09-30

86.12%

Inst. Shares: 63,038,703

Shares Outstanding: 73,200,000

2025-06-30

89.64%

Inst. Shares: 65,439,053

Shares Outstanding: 73,000,000

2025-03-31

80.68%

Inst. Shares: 58,491,481

Shares Outstanding: 72,500,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	51,878,117	64,000,000	81.06%
2025-12-31	53,884,280	70,900,000	76.00%
2025-09-30	63,038,703	73,200,000	86.12%
2025-06-30	65,439,053	73,000,000	89.64%
2025-03-31	58,491,481	72,500,000	80.68%
2024-12-31	69,628,431	71,900,000	96.84%
2024-09-30	66,649,959	72,100,000	92.44%
2024-06-30	66,551,166	71,900,000	92.56%
2024-03-31	62,424,257	71,700,000	87.06%
2023-12-31	60,202,641	55,500,000	108.47%
2023-09-30	45,016,065	54,100,000	83.21%
2023-06-30	42,917,951	53,400,000	80.37%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

ARVINAS, INC. (ARVN) — SEC Financial Statements & Analysis

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.